Kang B, Lee Y, Lim J, Yong D, Ki Choi Y, Woo Yoon S, Search engine optimization S, Jang S, Uk Son S, Kang T, et al. FRET-based hACE2 receptor mimic peptide conjugated nanoprobe for easy detection of SARS-CoV-2. Chem Eng J. 2022;442:136143.
Jeong H, Lee JJ, Lee J, Na Ok. A multiligand architectural photosensitizer that targets hemagglutinin on envelope of influenza virus for photodynamic inactivation. Small. 2020;16:2000556.
Jeong H, Lee CS, Lee J, Lee J, Hwang HS, Lee M, Na Ok. Hemagglutinin nanoparticulate vaccine with managed photochemical immunomodulation for pathogenic influenza-specific immunity. Adv Sci. 2021;8:2100118.
Ma X, Zou F, Yu F, Li R, Yuan Y, Zhang Y, Zhang X, Deng J, Chen T, Track Z, et al. Nanoparticle vaccines based mostly on the receptor binding area (RBD) and heptad repeat (HR) of SARS-CoV-2 elicit sturdy protecting immune responses. Immunity. 2020;53:1315–30.
Wang C, Wang S, Chen Y, Zhao J, Han S, Zhao G, Kang J, Liu Y, Wang L, Wang X, et al. Membrane nanoparticles derived from ACE2-rich cells block SARS-CoV-2 an infection. ACS Nano. 2021;15:6340–51.
Liu J, Liu Y, Xia H, Zou J, Weaver SC, Swanson KA, Cai H, Cutler M, Cooper D, Muik A, et al. BNT162b2-elicited neutralization of B.1.617 and different SARS-CoV-2 variants. Nature. 2021;596:273–5.
Wu CY, Kao SE, Tseng YC, Lin YP, Hou JT, Wu LY, Chiu S, Ma CA, Hsiao PW, Hsiao J, Chen JR. Pilot-scale manufacturing of inactivated monoglycosylated break up H1N1 influenza virus vaccine supplies cross-strain safety in opposition to influenza viruses. Antiviral Res. 2023;216:105640.
Atalis A, Keenum MC, Pandey B, Seashore A, Pradhan P, Vantucci C, O’Farrell L, Noel R, Jain R, Hosten J, et al. Nanoparticle-delivered TLR4 and RIG-I agonists improve immune response to SARS-CoV-2 subunit vaccine. J Managed Launch. 2022;347:476–88.
Ge C, Zhu J, Ye H, Wei Y, Lei Y, Zhou R, Track Z, Yin L. Rational building of protein-mimetic nano-switch techniques based mostly on secondary construction transitions of artificial polypeptides. J Am Chem Soc. 2023;145:11206–14.
Han X, Alameh MG, Butowska Ok, Knox JJ, Lundgreen Ok, Ghattas M, Gong N, Xue L, Xu Y, Lavertu M, et al. Adjuvant lipidoid-substituted lipid nanoparticles increase the immunogenicity of SARS-CoV-2 mRNA vaccines. Nat Nanotechnol. 2023;18:1105–14.
Mao T, Israelow B, Peña Hernández MA, Suberi A, Zhou L, Luyten S, Reschke M, Dong H, Homer RJ, Saltzman WM, Iwasaki A. Unadjuvanted intranasal spike vaccine elicits protecting mucosal immunity in opposition to sarbecoviruses. Science. 2022;378:2523.
Lam JH, Shivhare D, Chia TW, Chew SL, Sinsinbar G, Aw TY, Wong S, Venkataraman S, Lim FWI, Vandepapeliere P, Nallani M. Synthetic cell membrane polymersome-based intranasal beta spike formulation as a second era COVID-19 vaccine. ACS Nano. 2022;16:16757–75.
Aksyuk AA, Bansal H, Wilkins D, Stanley AM, Sproule S, Maaske J, Sanikommui S, Hartman WR, Sobieszczyk ME, Falsey AR, Kelly EJ. AZD1222-induced nasal antibody responses are formed by prior SARS-CoV-2 an infection and correlate with virologic outcomes in breakthrough an infection. Cell Rep Med. 2023;4:100882.
Zhang L, Jiang Y, He J, Chen J, Qi R, Yuan L, Shao T, Zhao H, Chen C, Chen Y, et al. Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters. Nat Commun. 2023;14:4117.
Meng QF, Tai W, Tian M, Zhuang X, Pan Y, Lai J, Xu Y, Xu Z, Li M, Zhao G, et al. Inhalation supply of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates. Sci Adv. 2023;9:3277.
Yang J, Liu MQ, Liu L, Li X, Xu M, Lin H, Li M, Yan H, Chen YQ, Shi ZL. The protecting nasal boosting of a triple-RBD subunit vaccine in opposition to SARS-CoV-2 following inactivated virus vaccination. Sign Transduct Goal Ther. 2023;8:151.
Lei H, Alu A, Yang J, He X, He C, Ren W, Chen Z, Hong W, Chen L, He X, et al. Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protecting immunity in opposition to omicron-included SARS-CoV-2 variants. Nat Commun. 2023;14:2678.
Gao A, Chen Y, Liang H, Cui X, Zhang A, Cui D. Growing an environment friendly MGCR microneedle nanovaccine patch for eliciting th 1 mobile response in opposition to the SARS-CoV-2 an infection. Theranostics. 2023;13:4821–35.
Gao ZL, Xu W, Zheng SJ, Duan QJ, Liu R, Du JZ. Orchestrated cytosolic supply of antigen and adjuvant by manganese ion-coordinated nanovaccine for enhanced most cancers immunotherapy. Nano Lett. 2023;23:1904–13.
Jia S, Ji S, Zhao J, Lv Y, Wang J, Solar D, Ding D. A fluorinated supramolecular self-assembled peptide as nanovaccine adjuvant for enhanced most cancers vaccine remedy. Small Strategies. 2023;7:2201409.
Guo X, Du L, Ma N, Zhang P, Wang Y, Han Y, Huang X, Zhang Q, Tan X, Lei X, Qu B. Monophosphoryl lipid A ameliorates radiation-induced lung damage by selling the polarization of macrophages to the M1 phenotype. J Transl Med. 2022;20:597.
Pifferi C, Fuentes R, Fernández-Tejada A. Pure and artificial carbohydrate-based vaccine adjuvants and their mechanisms of motion. Nat Rev Chem. 2021;5:197–216.
Zhao T, Cai Y, Jiang Y, He X, Wei Y, Yu Y, Tian X. Vaccine adjuvants: mechanisms and platforms. Sign Transduct Goal Ther. 2023;8:283.
Sliepen Ok, Schermer E, Bontjer I, Burger JA, Lévai RF, Mundsperger P, Brouwer PJM, Tolazzi M, Farsang A, Katinger D, et al. Interaction of numerous adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers. npj Vaccines. 2021;6:103.
Ukidve A, Cu Ok, Goetz M, Angsantikul P, Curreri A, Tanner EEL, Lahann J, Mitragotri S. Ionic-liquid-based protected adjuvants. Adv Mater. 2020;32:2002990.
Peng S, Cao F, Xia Y, Gao XD, Dai L, Yan J, Ma G. Particulate alum by way of pickering emulsion for an enhanced COVID-19 vaccine adjuvant. Adv Mater. 2020;32:2004210.
Phoolcharoen W, Shanmugaraj B, Khorattanakulchai N, Sunyakumthorn P, Pichyangkul S, Taepavarapruk P, Praserthsee W, Malaivijitnond S, Manopwisedjaroen S, Thitithanyanont A, et al. Preclinical analysis of immunogenicity, efficacy and security of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3 M-052-Alum adjuvant. Vaccine. 2023;41:2781–92.
Herman L, De Smedt SC, Raemdonck Ok. Pulmonary surfactant as a flexible biomaterial to combat COVID-19. J Managed Launch. 2022;342:170–88.
Wang S, Li Z, Wang X, Zhang S, Gao P, Shi Z. The position of pulmonary surfactants within the remedy of acute respiratory misery syndrome in COVID-19. Entrance Pharmacol. 2021;12:698905.
Hidalgo A, Garcia-Mouton C, Autilio C, Carravilla P, Orellana G, Islam MN, Bhattacharya J, Bhattacharya S, Cruz A, Pérez-Gil J. Pulmonary surfactant and drug supply: vehiculization, launch and focusing on of surfactant/tacrolimus formulations. J Managed Launch. 2021;329:205–22.
Guo L, Miao Y, Wang Y, Zhang Y, Zhou E, Wang J, Zhao Y, Li L, Wang A, Gan Y, Zhang X. Biomimetic macrophage membrane and lipidated peptide hybrid nanovesicles for atherosclerosis remedy. Adv Funct Mater. 2022;32:2204822.
Hu M, Zhang J, Kong L, Yu Y, Hu Q, Yang T, Wang Y, Tu Ok, Qiao Q, Qin X, Zhang Z. Immunogenic hybrid nanovesicles of liposomes and tumor-derived nanovesicles for most cancers immunochemotherapy. ACS Nano. 2021;15:3123–38.
Neupane YR, Handral HK, Alkaff SA, Chng WH, Venkatesan G, Huang C, Lee CK, Wang J-W, Sriram G, Dienzo RA, et al. Cell-derived nanovesicles from mesenchymal stem cells as extracellular vesicle-mimetics in wound therapeutic. Acta Pharm Sin B. 2023;13:1887–902.
Lee JR, Sim WS, Park HJ, Park BW, Joung YK. Focused supply of apoptotic cell-derived nanovesicles prevents cardiac transforming and attenuates cardiac perform exacerbation. Adv Funct Mater. 2023;33:2210864.
Solar L, Wang D, Noh I, Fang RH, Gao W, Zhang L. Synthesis of erythrocyte nanodiscs for bacterial toxin neutralization. Angew Chem Int Ed. 2023;62:2023015.
Li Z, Wang Z, Dinh PC, Zhu D, Popowski KD, Lutz H, Hu S, Lewis MG, Cook dinner A, Andersen H, et al. Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung damage in a non-human primate mannequin of COVID-19. Nat Nanotechnol. 2021;16:942–51.
Guo Z, Noh I, Zhu AT, Yu Y, Gao W, Fang RH, Zhang L. Most cancers cell membrane nanodiscs for antitumor vaccination. Nano Lett. 2023;23:7941–9.
Gao J, Su Y, Wang Z. Distant co-loading of amphipathic acid medicine in neutrophil nanovesicles infilled with ldl cholesterol mitigates lung bacterial an infection and irritation. Biomaterials. 2023;296:122071.
Chen HY, Deng J, Wang Y, Wu CQ, Li X, Dai HW. Hybrid cell membrane-coated nanoparticles: a multifunctional biomimetic platform for most cancers prognosis and remedy. Acta Biomater. 2020;112:1–13.
Zhou Y, Liang Q, Wu X, Duan S, Ge C, Ye H, Lu J, Zhu R, Chen Y, Meng F, Yin L. siRNA supply in opposition to myocardial ischemia reperfusion damage mediated by reversibly camouflaged biomimetic nanocomplexes. Adv Mater. 2023;35:2210691.
Krishnan N, Peng FX, Mohapatra A, Fang RH, Zhang L. Genetically engineered mobile nanoparticles for biomedical functions. Biomaterials. 2023;296:122065.
Cheng Q, Kang Y, Yao B, Dong J, Zhu Y, He Y, Ji X. Genetically engineered-cell‐membrane nanovesicles for most cancers immunotherapy. Adv Sci. 2023;10:2302131.
Huo J, Zhang A, Wang S, Cheng H, Fan D, Huang R, Wang Y, Wan B, Zhang G, He H. Splenic-targeting biomimetic nanovaccine for elevating protecting immunity in opposition to virus an infection. J Nanobiotechnol. 2022;20:514.
Alameh MG, Tombacz I, Bettini E, Lederer Ok, Sittplangkoon C, Wilmore JR, Gaudette BT, Soliman OY, Pine M, Hicks P, et al. Lipid nanoparticles improve the efficacy of mRNA and protein subunit vaccines by inducing sturdy T follicular helper cell and humoral responses. Immunity. 2021;54:2877–92.
McKay PF, Hu Ok, Blakney AK, Samnuan Ok, Brown JC, Penn R, Zhou J, Bouton CR, Rogers P, Polra Ok, et al. Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces excessive neutralizing antibody titers in mice. Nat Commun. 2020;11:3523.
Kim KS, Lee S, Na Ok, Bae YH. Ovalbumin and poly(i:c) encapsulated dendritic cell-targeted nanoparticles for immune activation within the small intestinal lymphatic system. Adv Healthc Mater. 2022;11:2200909.
Wang J, Li P, Yu Y, Fu Y, Jiang H, Lu M, Solar Z, Jiang S, Lu L, Wu MX. Pulmonary surfactant–biomimetic nanoparticles potentiate heterosubtypic influenza immunity. Science. 2020;367:869.
Chen X, Shi T, Yang C, Chen F, He X, Zhang Ok, Hu H, Cai L, Leong KW, Shao D. Scalable biomimetic SARS-CoV–2 nanovaccines with sturdy protecting immune responses. Sign Transduct Goal Ther. 2022;7:96.
Elia U, Rotem S, Bar Haim E, Ramishetti S, Naidu GS, Gur D, Aftalion M, Israeli Ma, Bercovich Kinori A, Alcalay R, et al. Lipid nanoparticle RBD-hFc mRNA vaccine protects hACE2 transgenic mice in opposition to a deadly SARS-CoV-2 an infection. Nano Lett. 2021;21:4774–9.
Yang Z, Hua L, Yang M, Liu SQ, Shen J, Li W, Lengthy Q, Bai H, Yang X, Ren Z, et al. RBD-modified bacterial vesicles elicited potential protecting immunity in opposition to SARS-CoV-2. Nano Lett. 2021;21:5920–30.
Pan J, Wang Q, Qi M, Chen J, Wu X, Zhang X, Li W, Zhang XE, Cui Z. An intranasal multivalent epitope-based nanoparticle vaccine confers broad safety in opposition to divergent influenza viruses. ACS Nano. 2023;17:13474–87.
Chen H, Jiang S, Zhang P, Ren Z, Wen J. Exosomes synergized with PIONs@E6 improve their immunity in opposition to hepatocellular carcinoma by way of selling M1 macrophages polarization. Int Immunopharmacol. 2021;99:107960.
Zhou Z, Deng T, Tao M, Lin L, Solar L, Track X, Gao D, Li J, Wang Z, Wang X, et al. Snail-inspired AFG/GelMA hydrogel accelerates diabetic wound therapeutic by way of inflammatory cytokines suppression and macrophage polarization. Biomaterials. 2023;299:122141.
Wang Z, Popowski KD, Zhu D, de Juan Abad BL, Wang X, Liu M, Lutz H, De Naeyer N, DeMarco CT, Denny TN, et al. Exosomes embellished with a recombinant SARS-CoV-2 receptor-binding area as an inhalable COVID-19 vaccine. Nat Biomed Eng. 2022;6:791–805.
He X, Chen X, Wang H, Du G, Solar X. Current advances in respiratory immunization: a concentrate on COVID-19 vaccines. J Managed Launch. 2023;355:655–74.
Brewer RC, Ramadoss NS, Lahey LJ, Jahanbani S, Robinson WH, Lanz TV. BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2. Nat Immunol. 2021;23:33–9.
Chen J, Wang B, Caserto JS, Shariati Ok, Cao P, Pan Y, Xu Q, Ma M. Sustained supply of SARS-CoV-2 RBD subunit vaccine utilizing a excessive affinity injectable hydrogel scaffold. Adv Healthc Mater. 2021;11:2101714.